Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Noninfectious complications of continuous peritoneal dialysis

Jean L Holley, MD, FACP
Rebecca J Schmidt, DO, FACP
Section Editor
Thomas A Golper, MD
Deputy Editor
Alice M Sheridan, MD


Some of the noninfectious complications that occur in patients on continuous peritoneal dialysis (eg, continuous ambulatory peritoneal dialysis [CAPD] and continuous cycler peritoneal dialysis [CCPD]) are due to increased intra-abdominal pressure resulting from instillation of dialysate into the peritoneal cavity. These include hernia formation, leaks (including hydrothorax or pleuroperitoneal leaks), local edema, back pain, and gastrointestinal problems, such as gastroesophageal reflux and delayed gastric emptying (see "Abdominal hernias in continuous peritoneal dialysis" and "Noninfectious complications of peritoneal dialysis catheters"). Complications of CAPD/CCPD not specifically related to intra-abdominal pressure include hemoperitoneum, pain on infusion of dialysate, electrolyte imbalances, and ultrafiltration failure.

Some of these problems will be reviewed here, including:

Gastroesophageal reflux and delayed gastric emptying

Back and abdominal pain

Pleural effusion


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Jan 15, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Björvell H, Hylander B. Functional status and personality in patients on chronic dialysis. J Intern Med 1989; 226:319.
  2. Dong R, Guo ZY. Gastrointestinal symptoms in patients undergoing peritoneal dialysis: multivariate analysis of correlated factors. World J Gastroenterol 2010; 16:2812.
  3. Hylander BI, Dalton CB, Castell DO, et al. Effect of intraperitoneal fluid volume changes on esophageal pressures: studies in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991; 17:307.
  4. Kim MJ, Kwon KH, Lee SW. Gastroesophageal reflux disease in CAPD patients. Adv Perit Dial 1998; 14:98.
  5. Lee YC, Hung SY, Wang HH, et al. Different Risk of Common Gastrointestinal Disease Between Groups Undergoing Hemodialysis or Peritoneal Dialysis or With Non-End Stage Renal Disease: A Nationwide Population-Based Cohort Study. Medicine (Baltimore) 2015; 94:e1482.
  6. Keshavarzian A, Iber FL, Vaeth J. Gastric emptying in patients with insulin-requiring diabetes mellitus. Am J Gastroenterol 1987; 82:29.
  7. Brown-Cartwright D, Smith HJ, Feldman M. Gastric emptying of an indigestible solid in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis. Gastroenterology 1988; 95:49.
  8. Bird NJ, Streather CP, O'Doherty MJ, et al. Gastric emptying in patients with chronic renal failure on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1994; 9:287.
  9. Fernström A, Hylander B, Grybäck P, et al. Gastric emptying and electrogastrography in patients on CAPD. Perit Dial Int 1999; 19:429.
  10. Seibert DG, Moss AH, Holley JL, Foulks CJ. Intraperitoneal metoclopramide improves symptoms of gastroparesis in a CAPD patient. Perit Dial Int 1989; 9:223.
  11. Moss AH. Therapy for diabetic gastroparesis. Semin Dial 1991; 4:125.
  12. Wadhwa NK, Atkins H, Cabralda T. Intraperitoneal erythromycin for gastroparesis. Ann Intern Med 1991; 114:912.
  13. Gallar P, Oliet A, Vigil A, et al. Gastroparesis: an important cause of hospitalization in continuous ambulatory peritoneal dialysis patients and the role of erythromycin. Perit Dial Int 1993; 13 Suppl 2:S183.
  14. Amin K, Bastani B. Intraperitoneal ondansetron hydrochloride for intractable nausea and vomiting due to diabetic gastroparesis in a patient on peritoneal dialysis. Perit Dial Int 2002; 22:539.
  15. Al-Hwiesh A, Al-Mueilo S, Saeed I, Al-Muhanna FA. Intraperitoneal pressure and intra-abdominal pressure: are they the same? Perit Dial Int 2011; 31:315.
  16. Dejardin A, Robert A, Goffin E. Intraperitoneal pressure in PD patients: relationship to intraperitoneal volume, body size and PD-related complications. Nephrol Dial Transplant 2007; 22:1437.
  17. Bargman JM. Complications of peritoneal dialysis related to increased intraabdominal pressure. Kidney Int Suppl 1993; 40:S75.
  18. Homodraka-Malis A. Pathogenesis and treatment of back pain in peritoneal dialysis patients. Perit Dial Bull 1983; 3(Suppl 3):S41.
  19. Nomoto Y, Suga T, Nakajima K, et al. Acute hydrothorax in continuous ambulatory peritoneal dialysis--a collaborative study of 161 centers. Am J Nephrol 1989; 9:363.
  20. García Ramón R, Carrasco AM. Hydrothorax in peritoneal dialysis. Perit Dial Int 1998; 18:5.
  21. Lew SQ. Hydrothorax: pleural effusion associated with peritoneal dialysis. Perit Dial Int 2010; 30:13.
  22. Abraham G, Shokker A, Blake P, Oreopoulos DG. Massive hydrothorax in patients on peritoneal dialysis: A literature review. Adv Perit Dial 1988; 4:121.
  23. Shemin D, Clark DD, Chazan JA. Unexplained pleural effusions in the peritoneal dialysis population. Perit Dial Int 1989; 9:143.
  24. Fletcher S, Turney JH, Brownjohn AM. Increased incidence of hydrothorax complicating peritoneal dialysis in patients with adult polycystic kidney disease. Nephrol Dial Transplant 1994; 9:832.
  25. Christidou F, Vayonas G. Recurrent acute hydrothorax in a CAPD patient: successful management with small volumes of dialysate. Perit Dial Int 1995; 15:389.
  26. Simmons LE, Mir AR. A review of management of pleuroperitoneal communication in five CAPD patients. Adv Perit Dial 1989; 5:81.
  27. Sudduth CD, Sahn SA. Pleurodesis for nonmalignant pleural effusions. Recommendations. Chest 1992; 102:1855.
  28. Hidai H, Takatsu S, Chiba T. Intrathoracic instillation of autologous blood in treating massive hydrothorax following CAPD. Perit Dial Int 1989; 9:221.
  29. Kanaan N, Pieters T, Jamar F, Goffin E. Hydrothorax complicating continuous ambulatory peritoneal dialysis: successful management with talc pleurodesis under thoracoscopy. Nephrol Dial Transplant 1999; 14:1590.
  30. Szeto CC, Chow KM. Pathogenesis and management of hydrothorax complicating peritoneal dialysis. Curr Opin Pulm Med 2004; 10:315.
  31. Pattison CW, Rodger RS, Adu D, et al. Surgical treatment of hydrothorax complicating continuous ambulatory peritoneal dialysis. Clin Nephrol 1984; 21:191.
  32. Vaamonde CA, Michael UF, Metzger RA, Carroll KE Jr. Complications of acute peritoneal dialysis. J Chronic Dis 1975; 28:637.
  33. Mactier RA, Sprosen TS, Gokal R, et al. Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int 1998; 53:1061.
  34. Bunchman TE, Ballal SH. Treatment of inflow pain by pH adjustment of dialysate in peritoneal dialysis. Perit Dial Int 1991; 11:179.
  35. Tranaeus A. A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution--clinical benefits. The Bicarbonate/Lactate Study Group. Perit Dial Int 2000; 20:516.
  36. Khan AN, Bernardini J, Johnston JR, Piraino B. Hypokalemia in peritoneal dialysis patients. Perit Dial Int 1996; 16:652.
  37. Oreopoulos DG, Khanna R, Williams P, Vas SI. Continuous ambulatory peritoneal dialysis - 1981. Nephron 1982; 30:293.
  38. Spital A, Sterns RH. Potassium supplementation via the dialysate in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1985; 6:173.
  39. Xu Q, Xu F, Fan L, et al. Serum potassium levels and its variability in incident peritoneal dialysis patients: associations with mortality. PLoS One 2014; 9:e86750.
  40. Tziviskou E, Musso C, Bellizzi V, et al. Prevalence and pathogenesis of hypokalemia in patients on chronic peritoneal dialysis: one center's experience and review of the literature. Int Urol Nephrol 2003; 35:429.
  41. Bargman, JM. Noninfectious complications of peritoneal dialysis. In: The Textbook of Peritoneal Dialysis, Gokal, R, Nolph, KD (Eds), Kluwer, Boston 1994. p.555.
  42. Amirmokri P, Morgan P, Bastani B. Intra-peritoneal administration of potassium and magnesium: a practical method to supplement these electrolytes in peritoneal dialysis patients. Ren Fail 2007; 29:603.
  43. Torlén K, Kalantar-Zadeh K, Molnar MZ, et al. Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort. Clin J Am Soc Nephrol 2012; 7:1272.
  44. Ribeiro SC, Figueiredo AE, Barretti P, et al. Low Serum Potassium Levels Increase the Infectious-Caused Mortality in Peritoneal Dialysis Patients: A Propensity-Matched Score Study. PLoS One 2015; 10:e0127453.
  45. Navarro JF, Mora C, García J, et al. Hypermagnesemia in CAPD. Relationship with parathyroid hormone levels. Perit Dial Int 1998; 18:77.
  46. Hutchinson AJ. Serum magnesium and end-stage renal disease. Perit Dial Int 1997; 17:327.
  47. Alhosaini M, Leehey DJ. Magnesium and Dialysis: The Neglected Cation. Am J Kidney Dis 2015; 66:523.
  48. Fein P, Weiss S, Ramos F, et al. Serum magnesium concentration is a significant predictor of mortality in peritoneal dialysis patients. Adv Perit Dial 2014; 30:90.